Harvard develops AI tool for identifying treatments for Parkinson’s and Alzheimer’s

The researchers at Harvard Medical School have created PDGrapher, an AI model designed to predict effective gene-drug combinations. Targeting diseases like Parkinson’s and Alzheimer’s, this tool enhances drug discovery by providing predictions and mechanistic insights.

Real-world testing indicates that PDGrapher can identify promising treatment pathways. This innovation reflects rapid advancements in AI and biotechnology, potentially transforming personalized medicine by allowing more tailored treatment approaches.